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Transjugular Access As An Alternative To Standard Transfemoral Approach
For Balloon Mitral Valvotomy In Patients With Structural Alterations
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Background: Percutaneous balloon mitral valvotomy (BMV) is the treatment of
choice for mitral stenosis and can be successfully done in majority of patients with
suitable morphology. However certain structural anomalies can make BMV using
femoral approach technically difﬁcult, or even impossible. A jugular approach can
overcome many of these constraints.
Methods: We evaluated patients at our center who underwent transjugular BMV.
In all the patients valve morphology was deemed suitable for BMV and the procedure
was done using an over the wire single cylindrical balloon technique. Transthoracic
echocardiogram before and after the procedure was done in all, to assess the valve
area, morphology and mitral regurgitation (MR). The procedure was undertaken in
27 patients during the study period (11 males, 3412 years).
Results: The transjugular BMV was completed in 26 out of 27 patients for the
following indications- failed femoral procedure (10 patients), large left atrium
(LA) (10 patients), inferior venacava anomalies (3 patients), dextrocardia (2 pa-
tients), scoliosis and rheumatic double outlet mitral valve (1 patient each). In
comparison with previous femoral BMV series’, our patients had several poor
prognostic factors including higher incidence of atrial ﬁbrillation (13 patients,
50%), prior cardiac surgery (5 patients, 19.2%), mean Wilkins score (8.41.2)
and larger mean LA size (5814mm). Procedural success was obtained in
24 patients and the mean valve area increased from 0.770.21 to 1.890.34
(p< 0.0001). Two patients developed severe MR and one required early mitral
valve replacement.
Conclusions: Transjugular BMV offers a safe and effective alternative to standard
transfemoral approach patients with anatomical alterations due to straight line access
to mitral valve. This technique thus avoids a certain surgery in these patients and
expands the role of catheter interventions in this common malady.Before BMV After BMV p value
Mean Pulmonary artery pressure
(mm Hg)
4218 3115 <0.0001
Mean Left atrial pressure
(mm Hg)
267 147 <0.0001
Mean Mitral valve gradient
(mm Hg)
17.56.2 3.73.1 <0.0001
Mean mitral valve area by 2-D planimetry
(mm Hg)
0.770.21 1.890.34 <0.0001TCT-807
Multi-Slice Computed Tomography Procedural Planning For Transcatheter
Mitral Annuloplasty
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Background: Transcatheter mitral annuloplasty (TMA) is an alternative therapy for
non-surgical patients with functional mitral regurgitation (FMR). Multi-slice CT-scan
(MSCT) has been used for device size selection and procedural planning. The aim of
the study is to report the average measurements of a population undergoing TMA with
the Cardioband device (Valtech Cardio, Israel).
Methods: MSCT of 16 consecutive patients undergoing TMA were prospectively
analyzed. Multiplanar reconstruction was used to mark the anatomical targets and to
determine the following variables: total annular size, posterior annular length (PAL),
valve area, ﬂuoroscopic working angle, distance of the circumﬂex artery and coronary
sinus, and height of the fossa ovalis. According to measurements, the position of
transeptal puncture and aim to the annulus were planned. Device size was chosen
according to PAL (oversizing by 20%).
Results: Total annular size and mitral valve area were 12614mm and 123cm2,
respectively. The posterior annular length (PAL) was 8413.3mm. The predicted
working angle was RAO 315. The circumﬂex artery was patent in 13 patients
(grafted in 4). The portion of the posterior annulus with the circumﬂex artery closer
than 8mm and of the coronary sinus closer than 10mm were 9.15.2% and
31.811%, respectively. The lowest rim of the fossa to the annulus distance was
2.80.6mm at the commissure.B236 JACC Vol 64/11/Suppl B j September 13–17, 2014 j TConclusions: TMA was successful and device sizing was appropriate in all patients.
No patient suffered coronary artery or coronary sinus injury.
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Background: Rheumatic heart disease remains the most common acquired heart
disease in children, especially in developing countries. This study aims to investigate
the predictors of immediate procedural success and the immediate and long-term
outcomes in patients undergoing percutaneous mitral commissurotomy (PTMC).
Methods: A total of 1552 patients with rheumatic mitral stenosis and underwent
PTMC from 1989 to 2012 were identiﬁed. We divided the group according to Wilkins
score as low risk (5), intermediate risk (6-8) and high-risk (9). Procedural success
was deﬁned as mitral valve area greater than 1.0cm2 with a mean gradient of less than
10mmHg.
Results: The median age was 36 years old [IQR 28-45]. The majority of patients was
female (78.5%) and did not have any other valve involvements (85.0%). Most of cases
were elective (99.5%) although 103 patients were pregnant (6.6%) during PTMC. The
mitral valve area increased from 0.8cm2 [IQR 0.7–1.0] pre-procedure to 1.5cm2 [IQR
1.3-1.7] post-procedure, with a reduction in the mean pressure gradient of 15mmHg
[IQR 12-20] to 4mmhg [IQR 2-6] post-procedure (all p< 0.05). Using logistic
regression analysis, no difference was seen in immediate procedural success between
increasing age, previous PTMC, emergency cases, New York Heart Association sta-
tus, balloon size or increasing risk groups (all p>0.05). During the 15-year follow-up,
the majority of patients were still alive.
Conclusions: PTMC appears to be safe and effective in our population, irrespective
of older age, higher NYHA class, higher Wilkins score and previous PTMC with
good immediate and long-term outcomes.CT Abstracts/Valvular disease - Mitral: Transcatheter therapies (non-MitraClip)
